Whalesbook
Zydus Wellness's integration of nearly ₹7,800 crore in acquisitions, particularly Comfort Click, has driven a significant 46.4% revenue increase to ₹3,940 crore in FY26. While this top-line growth is strong, the company is experiencing a year-on-year profit decline and ongoing margin pressures, showing that achieving profitable growth is still a challenge.
Revenue Surge Driven by Acquisitions
Zydus Wellness's net sales for FY26 reached ₹3,940 crore, up 46.4% from ₹2,691 crore in FY25. This growth was boosted by adding the UK-based Comfort Click, acquired for about ₹2,800 crore, which expanded the company's scale and market entry into the fast-growing Vitamins, Minerals, and Supplements (VMS) sector. However, while revenue grew significantly, EBITDA rose at a slower pace of 34.2% to ₹510 crore. This resulted in lower EBITDA margins of 12.9%, down from the previous year. Net profit after tax also fell year-over-year to ₹197 crore, mainly due to higher operating costs and interest expenses.
Valuation Concerns Amid Industry Trends
The Indian Fast-Moving Consumer Goods (FMCG) sector is showing resilience, with forecasts predicting high single-digit volume growth in 2026. This growth is expected from factors like easing inflation, GST benefits, recovering urban demand, and steady rural consumption. Many companies are focusing on premium products, wellness, and online sales, areas where Zydus Wellness's recent acquisitions, like Comfort Click, are well-positioned.
However, Zydus Wellness's valuation seems high when compared to competitors. Its price-to-earnings (P/E) ratio, between 77 and 124, is substantially higher than that of major companies like Hindustan Unilever (HUL) at around 46.8, and Nestle India. While Zydus Wellness's stock has performed strongly in the past, outpacing the Sensex over several years, its current high valuation might not fully reflect the risks of executing such large, debt-financed expansions.
The acquisition of Kraft Heinz India in late 2018 for ₹4,595 crore previously expanded Zydus's brands and market reach significantly, turning it into a larger FMCG player and briefly boosting its stock price by about 5%. However, that deal also led to higher interest costs and potential profit margin erosion. The Comfort Click acquisition further adds global reach and digital capabilities but also introduces complexity and financial pressure, with questions about its smooth integration and contribution to profits.
Financial Strains and Profitability Issues
Despite positive forecasts for the FMCG sector and Zydus Wellness's acquisition strategy, several challenges threaten its financial health and outlook. The company's debt, estimated between ₹2,800–₹3,000 crore for FY26, combined with a sharp rise in interest expenses from ₹4.20 crore to ₹38.70 crore in Q4 FY26, raises questions about its ability to manage its debt and maintain profitability.
Profit margins continue to shrink. Operating margins in Q4 FY26 dropped to 18.30% from 20.87% a year earlier, and net profit margins fell significantly to 10.97% from 18.88%. One analysis highlighted a major risk: 'Debt is not well covered by operating cash flow (5.9% operating cash flow to total debt)'. Zydus Wellness also reported a net loss of ₹39.90 crore in Q3 FY26, with operating margins hitting a low of 6.33%. These financial pressures stem partly from the costs of integrating acquisitions like Comfort Click and Naturell (RiteBite), as well as one-time costs and increased advertising spending.
Analyst opinions are divided. Some maintain a 'Buy' rating, pointing to growth potential and acquisition benefits. However, others, such as MarketsMOJO, rated the stock 'Sell' in March 2026, citing profitability problems and increasing debt. The company has also faced legal issues regarding its brands, including a Complan advertisement dispute and losing rights to the 'SugarLite' brand name. Although CEO Tarun Arora has a strong record and has led significant growth, an 'average' management risk assessment suggests the market sees some challenges in execution.
Outlook and Management Goals
Looking ahead, brokerage forecasts suggest FY27 revenue could reach around ₹5,700 crore, pointing to continued strong growth. Management plans to increase EBITDA margins to 17-18% over the next few years, excluding Comfort Click. Comfort Click itself is expected to add to earnings per share (EPS) from the first year after acquisition.
Major brands such as Sugar Free and Glucon-D continue to hold strong market positions. Zydus Wellness is also investing in new products and expanding its distribution, with a focus on rural areas and online sales. The Board has recommended a final dividend of ₹1.20 per share. The company's success in managing its debt, improving operations, and integrating its new acquisitions will be key to justifying its high valuation and meeting its long-term growth goals.